<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="species">human</item><item key="factors"><item><item key="GSM1414312"><item key="WEEKS OF TREATMENT">0</item><item key="DISEASE">alopecia areata</item><item key="TREATMENT">ruxolinitib</item></item></item><item><item key="GSM1414313"><item key="WEEKS OF TREATMENT">12</item><item key="DISEASE">alopecia areata</item><item key="TREATMENT">ruxolinitib</item></item></item><item><item key="GSM1414312"><item key="WEEKS OF TREATMENT">0</item><item key="DISEASE">alopecia areata</item><item key="TREATMENT">ruxolinitib</item></item></item><item><item key="GSM1414313"><item key="WEEKS OF TREATMENT">12</item><item key="DISEASE">alopecia areata</item><item key="TREATMENT">ruxolinitib</item></item></item><item><item key="GSM1414316"><item key="WEEKS OF TREATMENT">0</item><item key="DISEASE">normal</item><item key="TREATMENT">none</item></item></item><item><item key="GSM1414316"><item key="WEEKS OF TREATMENT">0</item><item key="DISEASE">normal</item><item key="TREATMENT">none</item></item></item><item><item key="GSM1414316"><item key="WEEKS OF TREATMENT">0</item><item key="DISEASE">normal</item><item key="TREATMENT">none</item></item></item></item><item key="id">4770</item><item key="pop_total">0</item><item key="platform">4</item><item key="summary_wrapped">Two patients with alopecia areata were treated with systemic ruxolitinib.  Skin biopsies were taken before starting treatment and 12...</item><item key="geo_gse_id">E-GEOD-58573</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">3</item><item key="sample_count">7</item><item key="tags"><item>alopecia</item><item>alopecia areata</item><item>scalp</item><item>skin</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_id_plat">E-GEOD-58573_A-AFFY-44</item><item key="slug">first-ruxolitinib-treatment-of-human-alopecia-area</item><item key="geo_gds_id"/><item key="name">First ruxolitinib treatment of human alopecia areata patients</item><item key="created">Sep.21, 2014</item><item key="summary">Two patients with alopecia areata were treated with systemic ruxolitinib.  Skin biopsies were taken before starting treatment and 12 weeks after starting treatment. We used microarrays to assess changes in gene expression of affected skin before and after starting treatment Two patients with alopecia areata were recruited for our study.  Skin biopsies of affected scalp were taken prior to starting treatment with oral ruxolinitib.  Additional skin biopsies were taken 12 weeks after starting treatment.  Scalp skin biopsies were taken from patients without alopecia areata for comparison.  RNA was extracted, cDNA libraries were made and profiled on affymetrix microarray chips.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-58573</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-58573/samples/</item></data></biogps>
